Shares of Catalyst Pharmaceuticals fell 4.09% to $3.64 at 14:37 EST on Thursday, after two consecutive sessions in a row of losses. The Nasdaq Stock Market is rising 0.68% to $12,744.50, after three consecutive sessions in a row of gains. This seems, up until now, a somewhat positive trend trading session today.

Catalyst Pharmaceuticals’s last close was $3.79, 45.25% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 11.6% for the ongoing quarter and 4.6% for the next. The company’s growth estimates for the ongoing quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.64 at 14:37 EST, way under its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is higher than its 50-day moving average of $3.42 and below its 200-day moving average of $3.79.

LEAVE A REPLY

Please enter your comment!
Please enter your name here